National Genetics Institute (NGI), a subsidiary of LabCorp, provides advanced clinical testing services to the biopharmaceutical industry and medical providers utilizing sophisticated applied genetics techniques. We have pioneered robust, sensitive, and automated methods for specimen nucleic acid testing. NGI screens the majority of the U.S. supply of Source Plasma for various infectious agents (HIV, HCV, HBV and others) using these PCR-based methods and has participated in numerous clinical studies in the area of infectious disease and oncology for major biopharmaceutical companies.